Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 75,834 shares at $117.38 ($8.9M) on 2026-08-13, disclosed to the SEC on 2026-08-14.
Scheduled sale ($8.9M) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |
| RYTM | SELL | 2025-02-04 | $172K | — | Filing → |